Leiter Competence Center Neue Technologien

Studium Biologie und Chemie Universität Freiburg, Staatsexamen 1980

Doktorarbeit in der Pflanzenphysiologie (Prof. Mohr), Promotion zum Dr. rer. nat. Universität Freiburg 1983

1983-1986: Wissenschaftlicher Angestellter der Universität Freiburg am Institut für Biologie II, Molekularbiologie der Pflanzen (Prof. Link, Prof. Schäfer)

1986-1987: Gastwissenschaftler (DFG-Stipendium) am DOE Plant Research Laboratory, Michigan State University, East Lansing, USA

seit 1987 wissenschaftlicher Mitarbeiter am Fraunhofer-Institut für System- und Innovationsforschung ISI, Projektleiter

1993-1995: Mitglied des Leitungsgremiums der Abteilung "Technischer und Industrieller Wandel"

1996-2004: Leiter der Abteilung "Innovationen in der Biotechnologie"

seit 2005 Leiter des Competence Centers Neue Technologien

August 2006 bis März 2007: stellvertretender Direktor

• Nationale und sektorale Innovationssysteme
• Innovationen im Gesundheitssystem
• Innovationspolitik
• Unternehmensstrategien von Biotechnologiefirmen
• Technikvorausschau und Technikfolgenabschätzung
• Makroökonomische Effekte neuer Technologien
• Technologiediffusion

• Wissenschafts- und Technikindikatoren
• öffentliche Wahrnehmung und Akzeptanz der Biotechnologie
• Innovation und Regulation

• Vorlesung: Management neuer Technologien, KIT Universität Karlsruhe

• Mitglied des Scientific Steering Committee des European Techno-Economic Policy Support Network (ETEPS)
• Mitglied des Peer Review Panels der European Science Foundation (ESF)

• Management of Emerging Technologies for Economic Impact (ManETEI)

• Emerging Research Areas and their Coverage by ERC-supported projects (ERACEP)
• Economic foresight study on industrial trends and the research needed to support the competitiveness of European industry around 2025 (NMP Foresight)
• Energiespeicher-Monitoring für die Elektromobilität (EMOTOR)
• Analyse des Gesundheitswesens aus Innovationssystemperspektive
• Synthetische Biologie - Studie für das Büro für Technikfolgenabschätzung beim Deutschen Bundestag
• Towards a European strategy for synthetic biology (TESSY)
• European Systems Biology
• Thematische Schwerpunktbildung in den Life Sciences durch systemimmanente Prozesse – eine systematische Analyse des Publikationsverhaltens in den Life Sciences (BioBias)
• FuE-Pipeline in den Life Sciences
• Integrated EST Framework (EST-Frame)
• Benchmarking of public biotechnology policies
• Efficiency of innovation policies in high-tech sectors in Europe
• European Biotechnology Innovation Systems
• Consequences, opportunities and challenges of modern biotechnology for Europe (Bio4EU)

Reiss, Thomas, Thielmann, Axel (2010): Nanotechnology Research in Russia - An Analysis of Scientific Publications and Patent Applications In: Nanotechnology Law & Business. 7 (2010), 4, S. 387-404. 
 
Gaisser, Sibylle; Reiss, Thomas; Lunkes, Astrid, Müller, Kristian M.; Bernauer, Hubert (2009): Making the most of synthetic biology. EMBO reports 10, Special Issue, S5-S8
Gaisser, Sibylle, Reiss, Thomas (2009): shaping the science-policy interface in synthetic biology. Syst Synth Biol 3, 109-114 
 
Enzing, Christien; Reiss, Thomas (2008): The Effectiveness of Biotechnology Policies in Europe. In: International Journal of Biotechnology 10, 4, pp. 327-340

Gaisser, Sibylle, Reiss, Thomas (2008): Biopharmaceutical Innovation Capacities – Benchmarking Europe. and Implications for CEE. Studies in Ethics, Law, and Technologies. Vol. 2: Iss. 2, Article 6, 22 p.

Reiss, Thomas; Dominguez-Lacasa, Iciar (2008): The Performance of European Countries in Biotechnology : How Does Europe Compare to the USA? In: International Journal of Biotechnology 10, 4, pp. 303-326

Senker, Jacqueline; Enzing, Christien; Reiss, Thomas (2008): Biotechnology Policies and Performance in Central and Eastern Europe. In: International Journal of Biotechnology 10, 4, pp. 341-362

Reiss, Thomas; Dominguez Lacasa, Iciar (2007): Benchmarking national biotechnology policy across Europe:A systems approach using quantitative and qualitative indicators. Research Evaluation 16(4), pp. 331.339

Senker, Jacqueline; Reiss, Thomas; Mangematin, Vincent; Enzing, Christien (2007):The Effects of National Policy on Biotechnology Development: the Need for a Braod Policy Approach. In: International Journal of Biotechnology 9.1, pp. 20-38.

Enzing, Christien; Reiss, Thomas; Gronning, Terje; Hinze, Sybille; Knell, Marc et al. (2006): Innovation in Pharmaceutical Biotechnology – Comparing National Innovation Systems at the Sectoral Level. Paris: OECD, 2006, 187 p.

Reiss, Thomas; Gaisser, Sibylle (2006): The Biotechnology for Europe Study (Bio4EU) – Consequences, Opportunities and Challenges of Modern Biotechnology for Europe. In: BioForum Europe 10.12, pp. 18-19.

Reiss, Thomas; Tait, Joyce (2005): Life Science Innovation: Policy and Foresight. In: Lyall, Catherine (Ed.) et al.: New Models of Governance: Developing an Integrated Policy Approach to Science, Technology, Risk and the Environment. Aldershop: Ashgate, pp. 69-87.

Reiss, Thomas; Diekmann, Wilfried (2005): The Take-off of European Systems Biology (EUSYSBIO): Benchmarking and Foresight of Systems Biology; Systems Biology Research in Central and Eastern European Countries and China. Stuttgart: Fraunhofer IRB Verlag (ISI-Schriftenreihe Innovationspotenziale).

Reiss, Thomas; Prats, Elena (2005): Les Politiques d'Innovation des Etats Membres de l'Union Européenne dans le Domaine de Biotechnologies. In: Réalités Industrielles (2005), 2, pp. 51-56.
Reiss, Thomas; Hinze, Sybille; Dominguez Lacasa, Iciar (2004): Performance of European Member States in Biotechnology. In: Science and Public Policy 31 (2004), 5, pp. 344-38.

Reiss, Thomas; Wörner, Stefan (2002): The Biotech Equipment and Supplies Sector in Europe – is it European? In: Journal of Biotechnology (2002), 98, S. 41-51.
Reiss, Thomas (2001): Success factors for Biotechnology – lessons from Japan, Germany, Great Britain. In: Int. J. Biotechnology 3, pp. 134-156.

Reiss, Thomas (2001): Drug discovery of the future: the implications of the human genome project. In: Trends in Biotechnology 19, pp. 496-499.

Senker, J.; Enzing, C.; Joly, P.-B.; Reiss, T. (2000): European Exploitation of Biotechnology – Do Government Policies Help? In: Nature Biotechnology 18 (2000), No. 6, pp. 605-608.

Reiss, Thomas; Strauss, Elke (1997): Patent Trend Profile: Development and Significance of Selected Biotechnological Methods for Drug Development: Immunological and Transformation Methods. In: Expert Opinion on Therapeutic Patents 7, pp. 743-752.